One aspect of the cannabis industry experts have advised investors about seeing major growth alongside the cannabis market is the ancillary and side services taking advantage of the legalization movement all across the world.

To provide a little bit of perspective on this, the Investing News Network (INN) had the opportunity to talk with Sean Dollinger, president and CEO of Namaste Technologies (CSE:N; OTC:NXTTF) about the company’s recently launched app-based platform NamasteMD for patients in Canada.


Namaste started by offering vaporizers and smoking accessories across the globe. Dollinger told INN they identified a correlation between people buying these products and cannabis users.

“Our whole idea is about being a platform, so LPs place their products on our platform; whereas we are the technology behind it,” Dollinger said.

Namaste previously earned some recognition in the industry when Aurora Cannabis (TSX:ACB; OTC:ACBFF) announced a hardware investment deal last year, which kicked off what has been a fruitful relationship between the companies.

The services of NamasteMD

Through a mobile app cannabis patients can input their data and be connected to a physician who offers cannabis as medicine. Then in the same app, the patient can have access to a catalogue of products from almost all LPs.

According to Dollinger Namaste has signed a service agreement with all the “top LPs” and are almost done signing every single LP in Canada.

The app has favorable reviews on Apple’s (NASDAQ:AAPL) own App Store and currently holds a five star rating based on 171 user reviews.

“We already have about 450 patients, and in March our target is to hit 1,500 patients… we’re aiming to have over 2,000 patients by the end of March,” Dollinger told INN, adding the company’s estimations for its year-end user base is currently 5,500 patients.

With all of the data Namaste will be collecting, which Dollinger told INN has not been decided,exactly, how to best monetize it, the company has plenty of options available on the consumer trends it will catalogue once more patients are using its service.

Namaste’s data collecting will also be enhanced by the option for patients to download a smartwatch app. Dollinger said Namaste will be able to give users specific information on the effects of the products available to patients in its service.

Investor Takeaway

As part of the company’s most recent sales update to investors, Namaste reported a 146 percent unaudited net revenue increase compared to the same month last year. The company said it expects these year-on-year growth marks to continue thanks to the complete legalization of cannabis in Canada this year.

“Our ability to provide patients with an all-inclusive e-commerce marketplace of cannabis products and services in the near term should serve to significantly increase our market share moving forward,” Dollinger said in Namaste’s statement.

Dollinger also told INN Namaste is in the works to upgrade its common stock both in Canada and the US. Namaste wants to move up to the TSX Venture exchange and move its stock from the OTCQB Best Market onto the Nasdaq.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less